MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹34 Cr | ₹31 Cr | ₹26 Cr | ₹26 Cr | ₹19 Cr |
What is the latest Total Debt ratio of MEDICAMEN BIOTECH ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹19 Cr |
How is Total Debt of MEDICAMEN BIOTECH Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 8.56 | |
| Mar2024 | ₹31 Cr | 21.02 | |
| Mar2023 | ₹26 Cr | -0.34 | |
| Mar2022 | ₹26 Cr | 37.07 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Debt of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹344.5 Cr | -1.2% | 6.4% | -44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -1.2% |
6.4% |
-44.3% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses